Pharma Industry News

AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells

Scientists used artificial intelligence to design CRISPR nucleases with properties not found in nature, achieving activity that matches or exceeds natural enzymes despite the proteins' complex, multi-domain structure. The post AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells appeared first on GEN – Genetic Engineering and Biotechnology News.

Source: Genetic Engineering & Biotechnology News

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]